Table 2

 Disease activity, function and anti-TNF indicated by the treating rheumatologist, with regard to country

CountrynBASDAI*BASFI*BASG*Night pain (0–10)*Patient global (0–10)*Raised ESR (yes, %)Raised CRP (yes, %)Start TNF blockers (yes, %)
BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; BASG, Bath Ankylosing Spondylitis Global assessment of disease activity; CRP, C reactive protein; ESR, erythrocyte sedimentation rate; TNF, Tumour necrosis factor.
*Values are mean (SD).
†Data are available for only 13 patients.
Australia1205.5 (2.3)5.5 (2.7)5.8 (2.5)4.7 (2.8)5.7 (2.5)39.255.478.3
Belgium974.3 (2.4)4.2 (2.7)5.2 (2.3)3.9 (3.2)4.9 (2.6)40.358.056.7
Canada944.6 (2.3)3.7 (2.8)4.8 (2.8)4.2 (2.7)4.5 (2.5)57.157.137.2
France1374.8 (1.2)3.8 (2.7)5.4 (2.5)4.3 (2.8)5.0 (2.6)58.853.345.3
Germany2004.2 (2.1)4.1 (2.6)5.3 (2.4)4.5 (2.8)5.0 (2.8)55.258.949.0
Italy1034.9 (2.2)4.6 (2.4)5.8 (2.4)4.8 (2.9)5.9 (2.6)60.862.068.0
Mexico1284.7 (2.7)4.5 (3.1)5.5 (3.0)4.5 (3.3)5.5 (2.9)50.045.741.4
The Netherlands984.1 (2.3)4.1 (2.6)5.0 (2.4)3.7 (2.9)4.3 (2.8)40.548.140.8
Spain1834.3 (2.3)3.8 (2.8)5.0 (2.3)3.8 (3.0)4.7 (2.6)56.762.038.3
UK475.1 (2.2)5.6 (2.6)4.7 (2.5)5.0 (2.9)5.5 (2.8)7.7†42.938.3
Total12074.6 (2.3)4.3 (2.8)5.3 (2.5)4.3 (2.9)5.1 (2.7)51.556.749.3